多巴胺激动剂的历史。从多巴胺的生理和药理学到催乳素瘤及帕金森病的治疗——一种主观观点。 - Suppr

Suppr

超能文献

A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson's disease - a subjective view.

作者信息

Horowski R

机构信息

NeuroBiotec GmbH, Berlin, Germany.

出版信息

J Neural Transm (Vienna). 2007 Jan;114(1):127-34. doi: 10.1007/s00702-006-0560-0. Epub 2006 Aug 10.

DOI:10.1007/s00702-006-0560-0

PMID:16897593

Abstract

摘要

相似文献

A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson's disease - a subjective view.多巴胺激动剂的历史。从多巴胺的生理和药理学到催乳素瘤及帕金森病的治疗——一种主观观点。

J Neural Transm (Vienna). 2007 Jan;114(1):127-34. doi: 10.1007/s00702-006-0560-0. Epub 2006 Aug 10.

[Drug therapy in Parkinson's disease].[帕金森病的药物治疗]

Ned Tijdschr Geneeskd. 1999 Jan 30;143(5):234-40.

Dopaminergic drugs in development for Parkinson's disease.正在研发用于治疗帕金森病的多巴胺能药物。

Adv Neurol. 2003;91:267-71.

Dopamine and eating behavior disorders in Parkinson's disease: A complex recipe.帕金森病中的多巴胺与饮食行为障碍：一个复杂的组合。

Mov Disord. 2019 Jun;34(6):767-768. doi: 10.1002/mds.27703.

Dopamine agonists in the treatment of prolactinoma: are they still first choice?多巴胺激动剂治疗泌乳素瘤：它们仍是首选吗？

Intern Med J. 2011 Feb;41(2):156-61. doi: 10.1111/j.1445-5994.2010.02410.x.

Should levodopa be used anymore?左旋多巴还应该继续使用吗？

Acta Neurol Belg. 2002 Dec;102(4):163-6.

Dopamine receptor agonists in the therapy of Parkinson's disease.多巴胺受体激动剂在帕金森病治疗中的应用

J Neural Transm (Vienna). 2004 Oct;111(10-11):1375-446. doi: 10.1007/s00702-003-0059-x. Epub 2003 Dec 29.

New pharmacotherapy for Parkinson's disease.帕金森病的新药物疗法。

Ann Pharmacother. 1997 Oct;31(10):1205-17. doi: 10.1177/106002809703101014.

Dopamine agonists in the treatment of Parkinson's disease.多巴胺激动剂在帕金森病治疗中的应用

Expert Rev Neurother. 2006 Jan;6(1):81-9. doi: 10.1586/14737175.6.1.81.

DA agonists -- non-ergot derivatives: ropinirole: management of Parkinson's disease.多巴胺激动剂——非麦角衍生物：罗匹尼罗：帕金森病的治疗

Mov Disord. 2002;17 Suppl 4:S98-102. doi: 10.1002/mds.5570.

引用本文的文献

Integrating Neurology and Psychiatry throughout Educational Curricula for Healthcare Professionals.在医疗保健专业人员的整个教育课程中整合神经学和精神病学。

J Exp Neurol. 2020;1(4):168-172. doi: 10.33696/neurol.1.026.

Cabergoline associated with first episode mania.卡麦角林与首发躁狂症相关。

Psychosomatics. 2012 Nov-Dec;53(6):595-600. doi: 10.1016/j.psym.2012.01.005. Epub 2012 May 31.

本文引用的文献

Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome.透皮利苏力特：重症不安腿综合征患者的短期疗效和耐受性研究

Sleep Med. 2006 Jan;7(1):31-5. doi: 10.1016/j.sleep.2005.05.007. Epub 2005 Sep 27.

Agonism at 5-HT2B receptors is not a class effect of the ergolines.5-HT2B受体激动作用并非麦角灵类药物的类效应。

Eur J Pharmacol. 2005 Apr 25;513(3):225-8. doi: 10.1016/j.ejphar.2005.03.010. Epub 2005 Apr 15.

Transdermal lisuride delivery in the treatment of Parkinson's disease.

J Neural Transm Suppl. 2004(68):89-95. doi: 10.1007/978-3-7091-0579-5_10.

New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance.对旧药的新担忧：麦角衍生物多巴胺激动剂引发的心脏瓣膜病作为药物警戒的一个典型案例

Mov Disord. 2004 Jun;19(6):611-3. doi: 10.1002/mds.20202.

Striatal plasticity and motor learning-importance of circadian rhythms, sleep stages and dreaming...纹状体可塑性与运动学习——昼夜节律、睡眠阶段及梦境的重要性……

Parkinsonism Relat Disord. 2004 Jul;10(5):315-7. doi: 10.1016/j.parkreldis.2004.03.005.

Apomorphine in Parkinson's disease.阿扑吗啡在帕金森病中的应用。

Trans Am Neurol Assoc. 1951;56:251-3.

Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum.当前临床使用的多巴胺受体激动剂：在人类纹状体中定义的多巴胺受体结合特征比较

J Neural Transm (Vienna). 2003 Oct;110(10):1119-27. doi: 10.1007/s00702-003-0027-5.

EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.中枢神经系统中单胺能神经元存在的证据。IV. 中枢神经系统中单胺能神经末梢的分布。

Acta Physiol Scand Suppl. 1965:SUPPL 247:37+.

ASCENDING SYSTEMS OF CATECHOLAMINE NEURONS FROM THE LOWER BRAIN STEM.来自脑桥下部的儿茶酚胺能神经元的上行系统

Acta Physiol Scand. 1964 Dec;62:485-6. doi: 10.1111/j.1748-1716.1964.tb10446.x.

EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.中枢神经系统中含单胺神经元存在的证据。I. 脑干神经元细胞体中单胺的证实。

Acta Physiol Scand Suppl. 1964:SUPPL 232:1-55.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验